Theme
Obesity
The anti-obesity drug market and its knock-on effects across health.
The anti-obesity drug market centers on incretin therapies that produce significant, sustained weight loss. Its growth carries knock-on effects across cardiovascular, metabolic, and other areas of health.
Companies · 8
Amgen Inc.AMGN
Market cap$203B
Conviction5 / 5
GLP-1Obesity
Read profileEli Lilly and CompanyLLY
Market cap$1.1T
Conviction5 / 5
GLP-1Obesity
Read profileMadrigal Pharmaceuticals, Inc.MDGL
Market cap$13B
Conviction4 / 5
Metabolic diseaseObesity
Read profileNovo Nordisk A/SNVO
Market cap$163B
Conviction4 / 5
GLP-1Obesity
Read profilePfizer Inc.PFE
Market cap$140B
Conviction3 / 5
Obesity
Read profileViking Therapeutics, Inc.VKTX
Market cap$4.0B
Conviction3 / 5
ObesityMetabolic disease
Read profileZealand Pharma A/SZEAL
Market cap$3.1B
Conviction3 / 5
ObesityGLP-1
Read profileStructure Therapeutics Inc.GPCR
Market cap$3.5B
Conviction2 / 5
ObesityGLP-1
Read profile